Suggestions are presented to improve the therapeutic use of antiepileptic drugs in countries that are economically weak and have a shortage of physicans. In such countries the introduction of only a small number of particularly effective and harmless antiepileptic drugs would be beneficial both from the viewpoint of health economics and from the viewpoint of the quality of care.